El interés en corto de Twist Bioscience da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Twist Bioscience. Los datos de interés en corto se actualizan cada dos semanas.

Twist Bioscience (NASDAQ:TWST) Bolsa, Informe de interés en corto

Twist Bioscience

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience Corporation - Common Stock

Twist Bioscience Corp

<ul>
<li>Initial loan proceeds of $782 million expected to be funded this month and balance of proceeds funded through planned construction period</li>
<li>DOE loan guarantee facilitates expansion of Sustainable Aviation Fuel capacity to 300 million gallons per year</li>
</ul>
INDIANAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) ("Calumet," "we," "our" or "us") announced today the closing of a $1.44 billion guaranteed loan facility with the U.S. Department of Energy ("DOE") Loan Programs Office ("LPO"). The loan will fund the construction and expansion of the renewable fuels facility owned by Montana Renewables, LLC ("Montana Renewables" or "MRL"), an unrestricted subsidiary of Calumet.
The expansion positions Montana Renewables as one of the largest Sustainable Aviation Fuel ("SAF") producers globally, enabling an increase in annual production capacity to approximately 300 million gallons of SAF and 330 million gallons of combined SAF and renewable diesel ("RD"). The planned expansion includes several key components: a second renewable fuels reactor (allowing approximately half of the 300-million-gallon SAF capability to be online by 2026), debottlenecking of existing units, installation of SAF blending and logistics assets, increased renewable hydrogen production, cogeneration for renewable electricity and steam, and on-site water treatment and recycling capabilities.

News

Financing

CLMT

Montana Renewables Announces Closing Of $1.44B DOE Loan Facility For Renewable Fuels And Biomass Energy Facility

Management

Kohl's To Cut Jobs; Kohl's To Close San Bernardino E-Commerce Fulfillment Center When Lease Ends In May, And 27 Underperforming Stores By April; Kohl's Expects Pretax Charges Of About $60M-$80M; San Bernardino EFC Is One Of 15 In Its Nationwide Supply Chain Network; Reaffirms 2024 Financial And Capital Allocation Outlook Excluding Charges

Offerings

BNED

Barnes & Noble Education Files For Mixed Shelf Of Up To $100M

ATKR

Atkore Inc Announced John W. Pregenzer As Chief Operating Officer In Addition To His Current Role As President-Electrical

Fourth Quarter-to-Date Comparable Sales Increased 10% Year-Over-Year
Company Reaffirms Fiscal 2025 Guidance
Participating in 2025 ICR Conference, January 13, 2025
Genesco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) announced today that comparable sales, including both stores and direct sales, increased 10% for the quarter-to-date period ended December 28, 2024. Same store sales increased 6% and sales for the Company's e-commerce businesses increased 20% on a comparable basis for that period. Comparable sales changes for each retail business for the period were as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="2" rowspan="1">
Quarter-to-Date (8 weeks ended December 28, 2024)
Comparable Sales vs. FY24
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Journeys Group</td>
<td colspan="1" rowspan="1">14%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schuh Group</td>
<td colspan="1" rowspan="1">3%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Johnston &amp; Murphy Group</td>
<td colspan="1" rowspan="1">-1%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Comparable Sales</td>
<td colspan="1" rowspan="1">10%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Same Store Sales</td>
<td colspan="1" rowspan="1">6%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Comparable E-commerce Sales</td>
<td colspan="1" rowspan="1">20%</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Earnings

Genesco Reports Q4-To-Date Comparable Sales Increased 10% YoY; Same Store Sales Increased 6% And Sales For The Co's E-Commerce Businesses Increased 20% On A Comparable Basis For That Period

NEOG

Neogen Files For Non-Timely 10-Q With U.S. SEC; Expects To Record An Impairment Charge Of $461.4M In Q2; Expects Form 10-Q Will Report Net Loss Of $456.3M For Qtr Ended Nov 30, 2024

2024 Fourth Quarter and Full-Year Financial Results
<ul>
<li>Preliminary revenue was approximately $11.7 million for the year, compared to $12.1 million in the prior year. While year-over-year revenues for consumable products increased by approximately 3%, overall revenue was down year-over-year due to lower revenues from capital sales of Pheno instruments compared to the prior year. &nbsp;</li>
<li>Ended the year with approximately $16.3 million in cash and cash equivalents, compared to $20.9&nbsp;million at the start of the fourth quarter, a reduction in cash and cash equivalents for the fourth quarter of 2024 of $4.5 million. This reflects our continued reduction in operating cash use over the prior quarters of 2024.</li>
</ul>

Guidance

AXDX

Accelerate Q4 Revenue Of $11.7 Vs $12.1M YoY, $16.3M Cash Ending 2024; 3% Rise In Consumable Revenue Amid Pheno Capital Sales Decline

Based on holiday results, the Company has updated its fiscal 2024 outlook. The Company now expects revenue growth, including retail sales and credit card revenues, of 1.5 to 2.5 percent versus the 53-week fiscal 2023, which includes an approximately 135 basis point unfavorable impact from the 53rd week, compared with its prior outlook of flat to 1.0 percent growth. Additionally, the Company expects comparable sales growth of 2.5 to 3.5 percent versus 52 weeks in fiscal 2023, compared with its prior outlook of 1.0 to 2.0 percent growth.

Nordstrom Updates Outlook, Now Sees Revenue Growth, Including Retail Sales And Credit Card Revenues, Of 1.5%-2.5% YoY Vs Prior Outlook Of 1% Growth; Expects Comparable Net Sales Growth Of 2.5%-3.5% YoY Vs Prior Outlook Of 1%-2% Growth

Nordstrom, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) today announced a total Company net sales increase of 4.9 percent and a comparable sales increase of 5.8 percent for the nine-week holiday period ended January 4, 2025, compared with the nine weeks ended December 30, 2023. For the Nordstrom banner, net sales increased 3.7 percent and comparable sales increased 6.5 percent, while Nordstrom Rack banner net sales increased 7.4 percent and comparable sales increased 4.3 percent.

Nordstrom Announces A Total Company Net Sales Increase Of 4.9% And A Comparable Sales Increase Of 5.8% For The Nine-Week Holiday Period Ended January 4, 2025, Compared With The Nine Weeks Ended December 30, 2023. For The Nordstrom Banner, Net Sales Increased 3.7% And Comparable Sales Increased 6.5%, While Nordstrom Rack Banner Net Sales Increased 7.4% And Comparable Sales Increased 4.3%

The earnings results for WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) for Q1 were made public on Friday, January 10, 2025 at 04:05 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
WD-40 beat estimated earnings by 8.0%, reporting an EPS of $1.39 versus an estimate of $1.29.
Revenue was up $13.08 million from the same period last year.
<h3>Previous Earnings Records</h3>
Last quarter the company missed on EPS by $0.11 which was followed by a 5.0% drop in the share price the next day.
Here's a look at WD-40's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.34</td>
<td>1.38</td>
<td>1.11</td>
<td>1.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.23</td>
<td>1.46</td>
<td>1.14</td>
<td>1.28</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>149.19M</td>
<td>145.80M</td>
<td>140.51M</td>
<td>134.37M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>155.99M</td>
<td>155.04M</td>
<td>139.10M</td>
<td>140.42M</td>
</tr>
</tbody>
</table>

To track all earnings releases for WD-40 <a href="https://www.benzinga.com/quote/WDFC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WDFC

WD-40 Earnings Review: Q1 Summary

Reiterated Fiscal Year 2025 Guidance
The Company reiterated the following fiscal year guidance on a pro forma basis, excluding the full fiscal year financial impact of the homecare and cleaning business portfolios the Company expects to divest in fiscal year 2025 and the impacts of a favorable non-cash income tax adjustment which the Company will discuss during its first fiscal quarter earnings call:
<ul>
<li>Net sales growth is from the pro-forma 2024 results is projected to be between 6 and 11 percent with net sales between $600 million and $630 million after adjusting for estimated translation impacts of foreign currency.</li>
<li>Gross margin for the full year is expected to be between 54 and 55 percent.</li>
<li>Advertising and promotion investments are projected to be around 6 percent of net sales.</li>
<li>Operating income is projected to be between $95 million and $100 million. This range reflects anticipated growth of between 6 to 12 percent compared to 2024 pro forma results.</li>
<li>The provision for income tax is expected to be around 24 percent.</li>
<li>Diluted earnings per share is expected to be between $5.20 and $5.45 based on an estimated 13.5 million weighted average shares outstanding. This range reflects anticipated growth of between 9 to 14 percent compared to 2024 pro forma results.</li>
</ul>
"Our first quarter results reflect strong execution and significant progress on our gross margin expansion initiatives," said Sara Hyzer, WD-40 Company's vice president, finance and chief financial officer. "We achieved gross margin of 54.8 percent, up 100 basis points from the prior year quarter, moving us significantly closer to our target of 55 percent. This improvement reflects favorable sales mix, and the benefit of various supply chain initiatives executed across the globe. As we look ahead, we remain confident in achieving our fiscal year 2025 guidance," concluded Hyzer.
This guidance is expressed in good faith and is based on management's current view of anticipated results on a pro forma basis. Unanticipated inflationary headwinds and other unforeseen events may further affect the Company's financial results. Net sales guidance is adjusted for estimated translation impact of foreign currency use weighted average fiscal year 2024 foreign currency exchange rates. In the event the Company is unsuccessful in the divestiture of its assets currently held for sale, its guidance would be positively impacted by approximately $23 million in net sales, approximately $6 million in operating income, and approximately $0.33 in diluted EPS for the full fiscal year.

WD-40 Company Reiterates FY25 Guidance, Sees Net Sales Of $600M-$630M, 6%-11% Growth Vs $622.95M; Gross Margin 54-55%, Advertising/Promotion 6% Of Sales; Operating Income $95M-$100M; Income Tax Provision 24%, EPS $5.20-$5.45 Vs $5.36 Est.

At least 10 people have been killed in the Los Angeles fires this week, with over 9,000 structures destroyed, according to the latest estimates <a href="https://www.latimes.com/california/live/pacific-palisades-fire-updates-los-angeles">cited</a> by the L.A. Times.
What Happened: Several wildfires broke out on Tuesday and Wednesday in Los Angeles following <a href="https://www.benzinga.com/25/01/42855962/los-angeles-ventura-counties-brace-for-windstorm-as-bad-as-it-gets-for-fire-weather">a strong windstorm</a>. While officials are slowly containing the blaze, the economic damage amounts to <a href="https://www.benzinga.com/news/25/01/42922091/spacex-apple-airbnb-and-more-companies-pitch-in-to-support-california-residents-after-wildfires-we-want-to-help">the most devastating</a> in the city&#8217;s history.
The windstorm created a severe fire risk and several fires are still burning on Friday, the Los Angeles Times <a href="https://www.latimes.com/wildfires-map/?fire=palisades">reported</a>.
The blaze that began in Pacific Palisades burned over 20,000 acres of land. As of Friday, it is 8% contained.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Every kid in the US learns of the Great Chicago Fire (2,112 acres) in school and how modern building codes &amp; fire depts have made this impossible, yet both the 2023 Lahaina &amp; the current Palisades Fire crossed 17,000 acres &#8211; 8x the size! I marked up a map of Chicago to compare. <a href="https://t.co/jXiRWUosCE">pic.twitter.com/jXiRWUosCE</a>
&mdash; Shaun Cooley (@shauncooley) <a href="https://twitter.com/shauncooley/status/1877410391443255485?ref_src=twsrc%5Etfw">January 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">The fire is nearly 10 times larger than the Great Chicago Fire of 1871. Analysts project the total economic damage to range from $50 billion to $150 billion, <a href="https://www.washingtonpost.com/business/2025/01/09/los-angeles-wildfire-economic-losses/">according </a>to the Washington Post.</figcaption></figure>
The Eaton Fire in Altadena and the San Gabriel Valley has burned over 13,000 acres and is merely 3% contained. Other fires are burning north of Calabasas and near Santa Clarita.
Over 200,000 Californians were without power on Friday, <a href="https://poweroutage.us/">according </a>to Power Outage.
Experts <a href="https://www.bbc.com/news/articles/c0ewe4p9128o">attribute </a>the increase in wildfires in recent years to the effects of climate change.
Why it Matters: Several companies with operations in Los Angeles are exposed to the fires.
Shares of Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>), the region&#8217;s utility provider, have tumbled more than 18% since Monday. Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>), another utility provider, saw its shares sink more than 10%.
Insurance providers Chubb Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>), Travelers Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) and Allstate Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) saw their share prices deep in the red on Friday. Shares of Mercury General Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCY#NYSE">MCY</a>) fell over 20%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42922299/wall-street-tumbles-on-blowout-payrolls-oil-rallies-to-76-us-dollar-hits-26-month-highs-whats-driving-markets-friday">Wall Street Tumbles On Blowout Payrolls, Oil Rallies To $76, US Dollar Hits 26-Month Highs: What&#8217;s Driving Markets Friday? </a></li>
</ul>
Image: Shutterstock

Equities

Markets

10 Dead, 9,000 Structures Damaged In Los Angeles Wildfires: The Latest

WD-40 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.29 by 7.75 percent. This is a 8.59 percent increase over earnings of $1.28 per share from the same period last year. The company reported quarterly sales of $153.50 million which beat the analyst consensus estimate of $147.47 million by 4.08 percent. This is a 9.31 percent increase over sales of $140.42 million the same period last year.

Earnings Beats

WD-40 Q1 EPS $1.39 Beats $1.29 Estimate, Sales $153.50M Beat $147.47M Estimate

<h3>Gainers</h3>
<ul>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock increased by 50.0% to $2.28 during Friday's pre-market session. The market value of their outstanding shares is at $6.4 million. </li>
<li>Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) stock increased by 13.84% to $10.77. The company's market cap stands at $1.5 billion. </li>
<li>China Automotive Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAAS#NASDAQ">CAAS</a>) stock moved upwards by 12.12% to $4.44. The market value of their outstanding shares is at $134.0 million. </li>
<li>Wah Fu Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>) stock moved upwards by 9.7% to $1.83. The market value of their outstanding shares is at $8.1 million. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) stock rose 8.27% to $3.28. The company's market cap stands at $7.1 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) stock rose 8.14% to $2.92. The market value of their outstanding shares is at $8.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Emerson Radio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MSN#AMEX">MSN</a>) stock declined by 9.2% to $0.49 during Friday's pre-market session. The company's market cap stands at $10.3 million. </li>
<li>Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) stock decreased by 8.18% to $1.91. The market value of their outstanding shares is at $86.5 million. </li>
<li>ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) stock fell 8.08% to $0.9. The company's market cap stands at $28.3 million. </li>
<li>China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares declined by 7.43% to $3.24. The market value of their outstanding shares is at $94.7 million. </li>
<li>MGO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) stock decreased by 7.05% to $0.52. The company's market cap stands at $2.3 million. </li>
<li>Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) stock fell 6.91% to $15.78. The market value of their outstanding shares is at $12.7 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AACG

AMST

ARHS

CAAS

CLEU

FFIE

JWEL

MBLY

MGOL

VMAR

WAFU

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) shares moved upwards by 49.8% to $6.74 during Friday's pre-market session. The company's market cap stands at $51.7 million. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) stock increased by 36.44% to $1.61. The market value of their outstanding shares is at $4.0 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares rose 32.8% to $0.11. The market value of their outstanding shares is at $13.0 million. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) stock rose 24.06% to $3.3. The market value of their outstanding shares is at $163.5 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares rose 22.83% to $4.25. The market value of their outstanding shares is at $3.6 million. </li>
<li>Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) stock increased by 18.33% to $0.51. The company's market cap stands at $303.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) stock fell 67.8% to $2.0 during Friday's pre-market session. The market value of their outstanding shares is at $118.9 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) stock declined by 31.8% to $0.92. The company's market cap stands at $17.3 million. </li>
<li>Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) shares decreased by 18.47% to $1.06. The company's market cap stands at $130.9 million. </li>
<li>Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) stock declined by 13.8% to $19.87. The market value of their outstanding shares is at $2.0 billion. </li>
<li>TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) stock declined by 13.18% to $62.99. The market value of their outstanding shares is at $2.1 billion. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock declined by 12.36% to $1.49. The company's market cap stands at $60.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKYA

CLDI

DHAI

DTIL

IGMS

MRSN

SCNI

SENS

TMDX

ZVSA

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) shares moved upwards by 38.5% to $2.59 during Friday's pre-market session. The market value of their outstanding shares is at $834.3 million. </li>
<li>Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) shares increased by 31.89% to $3.68. The company's market cap stands at $199.4 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) stock increased by 19.66% to $2.13. The company's market cap stands at $11.2 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock increased by 15.99% to $4.93. The market value of their outstanding shares is at $5.4 million. </li>
<li>Art's-Way Manufacturing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTW#NASDAQ">ARTW</a>) shares moved upwards by 12.47% to $2.07. The company's market cap stands at $10.4 million. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) stock rose 12.18% to $5.8. The company's market cap stands at $75.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) stock fell 9.6% to $18.74 during Friday's pre-market session. The company's market cap stands at $2.2 billion. </li>
<li>SolarMax Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) stock fell 8.58% to $1.28. The company's market cap stands at $57.9 million. </li>
<li>Shengfeng Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFWL#NASDAQ">SFWL</a>) shares declined by 8.5% to $0.97. The company's market cap stands at $80.0 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock declined by 7.92% to $2.56. The company's market cap stands at $612.5 million. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock decreased by 7.49% to $2.1. The market value of their outstanding shares is at $3.4 million. </li>
<li>Ameresco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) shares declined by 7.24% to $25.14. The market value of their outstanding shares is at $1.3 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMRC

AREB

ARTW

BAER

GPUS

KULR

MVST

SFWL

SMXT

ZCAR

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock rose 26.9% to $2.69 during Friday's pre-market session. The market value of their outstanding shares is at $55.2 million. </li>
<li>BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares rose 25.69% to $1.81. The market value of their outstanding shares is at $5.6 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock moved upwards by 22.82% to $0.46. The market value of their outstanding shares is at $24.0 million. </li>
<li>Boxlight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOXL#NASDAQ">BOXL</a>) shares increased by 17.62% to $1.0. The market value of their outstanding shares is at $9.8 million. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) shares rose 15.29% to $1.88. The market value of their outstanding shares is at $176.3 million. </li>
<li>WISeKey Intl Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock rose 13.96% to $7.49. The market value of their outstanding shares is at $83.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) stock declined by 17.5% to $1.13 during Friday's pre-market session. The company's market cap stands at $40.3 million. </li>
<li>Lightwave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) stock decreased by 15.84% to $1.86. The market value of their outstanding shares is at $227.6 million. </li>
<li>Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) stock declined by 8.74% to $9.3. The company's market cap stands at $25.6 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock decreased by 8.54% to $0.55. The company's market cap stands at $11.8 million. </li>
<li>Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) stock fell 8.01% to $15.39. The company's market cap stands at $171.0 million. </li>
<li>Focus Universal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) stock fell 7.21% to $0.62. The market value of their outstanding shares is at $45.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKYI

BOXL

FCUV

GRRR

GRYP

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

LDTC

LWLG

NSYS

REKR

WKEY

12 Information Technology Stocks Moving In Friday's Pre-Market Session

WIIM

SWTX

SpringWorks Therapeutics shares are trading higher amid rumors of takeover interest.

Castellum Files For Mixed Shelf Offering Up To $100M

VOXX

VOXX International Files Form 12b-25 For Late Form 10-Q Due To Impairment Analysis Following Gentex Merger Agreement

Baird raised the firm's price target on Twist Bioscience (TWST) to $48 from $46 and keeps an Outperform rating on the shares. The firm said they re...

Twist Bioscience price target raised to $48 from $46 at Baird

Scotiabank analyst Sung Ji Nam reiterated a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $54.00. The com...

Twist Bioscience (TWST) Gets a Buy from Scotiabank

Scotiabank raised the firm's price target on Twist Bioscience (TWST) to $54 from $50 and keeps an Outperform rating on the shares. The company wrap...

Twist Bioscience price target raised to $54 from $50 at Scotiabank

Puneet Souda, an analyst from Leerink Partners, maintained the Hold rating on Twist Bioscience (TWST – Research Report). The associated price targe...

Cautious Outlook for Twist Bioscience Amid Regulatory Changes and Competitive Pressures

Analyst Brendan Smith from TD Cowen reiterated a Buy rating on Twist Bioscience (TWST – Research Report) and keeping the price target at $58.00. Br...

Twist Bioscience: Strategic Strengths and Promising Outlook Drive Buy Rating

TD Cowen analyst Brendan Smith named Twist Bioscience (TWST) a Best Idea for 2025 while keeping a Buy rating on the shares with a $58 price target ...

Twist Bioscience named a Best Idea for 2025 at TD Cowen

Twist Bioscience: Path To Profitability Beginning To Take Shape

Wolfe Research initiated coverage of Twist Bioscience (TWST) with an Outperform rating and $60 price target Published first on TheFly – the ultimat...

Twist Bioscience initiated with an Outperform at Wolfe Research

As previously reported, Wolfe Research initiated coverage of Twist Bioscience (TWST) with an Outperform rating and $60 price target Twist, which ha...

Wolfe sees 'clear path' to upside, starts Twist Bioscience at Outperform

In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on Twist Bioscience (TWST – Research Report), with a price target o...

TD Cowen Keeps Their Buy Rating on Twist Bioscience (TWST)

TWST

Press Releases

Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

Small Cap

Opinion

AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

Comments

Twist Bioscience

Interés en corto

Twist Bioscience (NASDAQ:TWST) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL